SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-019124
Filing Date
2022-09-30
Accepted
2022-09-30 17:15:47
Documents
12
Period of Report
2022-09-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K cycn-20220930.htm   iXBRL 8-K 59444
  Complete submission text file 0000950170-22-019124.txt   185905

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cycn-20220930_lab.xml EX-101.LAB 18519
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cycn-20220930_pre.xml EX-101.PRE 11504
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cycn-20220930.xsd EX-101.SCH 2477
6 EXTRACTED XBRL INSTANCE DOCUMENT cycn-20220930_htm.xml XML 4876
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 221284939
SIC: 2834 Pharmaceutical Preparations